Implemented globally as a post-marketing surveillance tool, the Save Sight Registries facilitates for the collection of anonymised data from different time- and end-points to investigate the natural history of treated and untreated ophthalmic diseases. This includes patient-focused outcomes such as treatment safety, treatment regimen, patient preference and perception of outcomes, quality of life, and long-term effectiveness of treatments. As a result, this registry can identify small but significant treatment effects that may improve the management of a patient’s eye disease. It also generates new research questions.
Data collected from this registry will be used to develop best practice guidelines and policies for the management of the studied ophthalmic diseases.